← ANALYSTS · TIPRANKS
Gil Blum · Needham
Hits
43%
216 of 499 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating
+12.5%
Over a year after the rating, TipRanks’ measure
Our companies rated now
18
Buy / hold / sell: 16 / 1 / 1
Upside of the analyst’s targets
+282.9%
Average over 16 current targets, to the last price
The market’s answer to the ratings
−2.3%
Day-0 move against SPY in the rating’s direction, average over 4 upgrades, downgrades and target changes
| Date · added, NY | Stock | Action | Rating | Price target | Upside | Move vs SPY | |
|---|---|---|---|---|---|---|---|
| Oct 7on TipRanks Oct 8 04:50 | RCKTIWMRocket Pharmaceuticals · $259M | Reiterated | Buy | $9.00 | +312.8% | +2.5%next day +4.2% · 5 days −11.8% | ↗ |
| Oct 5on TipRanks 07:14 | NKTXIWMNkarta · $138M | Reiterated | Buy | $11.00 | +511.1% | −2.4%next day −9.2% · 5 days −14.7% | ↗ |
| Oct 5on TipRanks 06:55 | FATEFate Therapeutics · $278M | Reiterated | Hold | — | — | +4.1%next day −6.3% · 5 days −12.8% | ↗ |
| Oct 5on TipRanks 06:45 | CRSPIWMCrispr Therapeutics AG · $5.0B | Reiterated | Buy | $82.00 | +66.5% | +2.8%next day −6.4% · 5 days −10.5% | ↗ |
| Oct 2on TipRanks 13:55 | AUTLAutolus Therapeutics · $474M | Reiterated | Buy | $10.00 | +525.0% | −4.5%next day +2.1% · 5 days +0.5% | ↗ |
| Oct 1on TipRanks 12:11 | ARTVIWMArtiva Biotherapeutics, Inc. · $289M | Reiterated | Buy | $41.00 | +600.9% | −4.8%next day −0.2% · 5 days −1.2% | ↗ |
| Sep 30on TipRanks 11:50 | CELCIWMCelcuity · $2.9B | Reiterated | Buy | $140 → $134−4.3% | +136.8% | +3.0%next day −5.7% · 5 days −19.2% | ↗ |
| Sep 29on TipRanks 12:55 | IMMXIWMImmix Biopharma · $720M | Reiterated | Buy | $21.00 → $30.00+42.9% | +275.9% | −7.9%next day −1.1% · 5 days −10.5% | ↗ |
| Sep 29on TipRanks 12:45 | RNACIWMCartesian Therapeutics · $199M | Reiterated | Buy | $40.00 | +538.0% | +0.6%next day −0.2% · 5 days −8.7% | ↗ |
| Sep 28on TipRanks 08:15 | SRPTIWMSarepta Therapeutics · $1.9B | Reiterated | Sell | — | — | +1.4%next day −0.7% · 5 days −8.2% | ↗ |
| Sep 23on TipRanks 07:55 | ABSIIWMAbSci · $1.5B | Reiterated | Buy | $11.00 | +33.3% | −8.3%next day +6.2% · 5 days +11.2% | ↗ |
| Sep 16on TipRanks 06:25 | RCKTIWMRocket Pharmaceuticals · $259M | Upgrade | Buy | $9.00 | +312.8% | +2.5%next day −0.6% · 5 days −15.3% | ↗ |
| Sep 11on TipRanks 06:50 | LYELIWMLyell Immunopharma · $196M | Reiterated | Buy | $44.00 | +441.9% | −2.8%next day −4.8% · 5 days −7.9% | ↗ |
| Aug 31on TipRanks Sep 1 04:50 | CRSPIWMCrispr Therapeutics AG · $5.0B | Reiterated | Buy | $82.00 | +66.5% | −1.0%next day +0.4% · 5 days −3.7% | ↗ |
| Aug 21on TipRanks 05:55 | FTHFaeth Therapeutics · $517M | Initiated | Buy | $56.00 | +197.9% | −0.7%next day +8.8% · 5 days +5.3% | ↗ |
| Aug 12on TipRanks 06:45 | TSHAIWMTaysha Gene Therapies · $1.2B | Reiterated | Buy | $12.00 | +231.5% | −4.4%next day −7.2% · 5 days +0.8% | ↗ |
| Aug 11on TipRanks 07:05 | NKTXIWMNkarta · $138M | Reiterated | Buy | $11.00 | +511.1% | −5.0%next day +2.3% · 5 days +3.8% | ↗ |
| Aug 7on TipRanks 04:36 | ARTVIWMArtiva Biotherapeutics, Inc. · $289M | Reiterated | Buy | $41.00 | +600.9% | −3.3%next day −0.4% · 5 days +1.2% | ↗ |
| Aug 7on TipRanks 02:35 | SLDBIWMSolid Biosciences · $615M | Reiterated | Buy | $19.00 | +243.6% | −4.3%next day +2.1% · 5 days +9.3% | ↗ |
| Aug 5on TipRanks 15:06 | RXRXIWMRecursion Pharmaceuticals · $2.2B | Reiterated | Buy | $8.00 | +130.9% | −4.0%next day +0.5% · 5 days +3.4% | ↗ |
| Aug 5on TipRanks 14:35 | GERNIWMGeron · $790M | Reiterated | Buy | $4.00 | +241.9% | +21.8%next day −3.5% · 5 days −4.0% | ↗ |
| Aug 4on TipRanks 08:32 | NRIXIWMNurix Therapeutics · $2.7B | Reiterated | Buy | $34.00 | +39.2% | +4.5%next day +1.9% · 5 days +5.2% | ↗ |
| No ratings for this filter. | |||||||
Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗